Business Description
Allarity Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US0167443029
Description
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.81 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | -71.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 78.74 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.75 | |||||
| Cash Ratio | 2.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -699.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -465 | |||||
| ROA % | -105.57 | |||||
| ROIC % | -126.1 | |||||
| 3-Year ROIIC % | 45.81 | |||||
| ROC (Joel Greenblatt) % | -95177.08 | |||||
| ROCE % | -396.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.22 | |||||
| Price-to-Tangible-Book | 0.22 | |||||
| EV-to-EBIT | 0.68 | |||||
| EV-to-EBITDA | 0.69 | |||||
| EV-to-FCF | 0.79 | |||||
| Price-to-Net-Current-Asset-Value | 0.22 | |||||
| Price-to-Net-Cash | 0.26 | |||||
| Earnings Yield (Greenblatt) % | 147.06 | |||||
| FCF Yield % | -343.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Allarity Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -840.274 | ||
| Beta | -0.79 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 41491.2 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 41491.19917 - 41491.200041 | ||
| Shares Outstanding (Mil) | 4.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Allarity Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Allarity Therapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Allarity Therapeutics Inc Frequently Asked Questions
What is Allarity Therapeutics Inc(FRA:C6D0)'s stock price today?
The current price of FRA:C6D0 is €41491.20. The 52 week high of FRA:C6D0 is €41491.20 and 52 week low is €41491.20.
When is next earnings date of Allarity Therapeutics Inc(FRA:C6D0)?
The next earnings date of Allarity Therapeutics Inc(FRA:C6D0) is 2025-03-01 Est..
Does Allarity Therapeutics Inc(FRA:C6D0) pay dividends? If so, how much?
Allarity Therapeutics Inc(FRA:C6D0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers